Here you find Investor News of year 2001.
Ad-hoc messages issued in year 2001 can be found here.
Publications of the previous years are offered in the Archive Overview.
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
Receive our IR news via E-Mail, RSS Feed or SMS.
December 07, 2001 | Vardenafil: Up to 85 Percent of Men Achieved Significantly Improved Erections
|
December 06, 2001 | Bayer to establish management holding company with operating subsidiaries
|
December 04, 2001 | Bayer Receives FDA Approval for the Intravenous Form of Its Antibiotic Avelox® (moxifloxacin HCl)
|
November 15, 2001 | Worldwide co-promotion agreement for vardenafil to treat erectile dysfunction
|
November 14, 2001 | Earnings hampered by weak global economy and problems with Pharmaceuticals
|
November 06, 2001 | Number of Bayer stockholders has risen by 100,000
|
October 02, 2001 | Bayer acquires Aventis Crop Science
|
September 25, 2001 | Bayer files applications for Vardenafil in United States and Mexico
|
September 13, 2001 | Bayer plans to form separate companies for Health Care and Crop Protection
|
September 13, 2001 | Werner Wenning will be new Bayer CEO
|
August 23, 2001 | Bayer withdraws cholesterol-lowering drug in Japan too
|
August 17, 2001 | Facts prove that Bayer gave authorities proper notification
|
August 17, 2001 | Bayer says claims are without foundation
|
August 16, 2001 | Bayer postpones listing on Wall Street
|
August 09, 2001 | Sales increase, but earnings down
|
August 08, 2001 | Bayer withdraws cholesterol-lowering drug Baycol/Lipobay
|
July 16, 2001 | Bayer included in ethics indices
|
July 10, 2001 | Bayer aims to acquire Aventis CropScience
|
June 27, 2001 | Earnings forecast revised in the face of economic downturn
|
June 12, 2001 | Bayer's pharmaceutical research strategy pays off: more than 40 substances in the pipeline
|
May 22, 2001 | Epidauros signs contract with Bayer
|
April 27, 2001 | Sales up 10 percent in the first quarter of 2001
|
April 24, 2001 | Bayer is looking for partners for its manmade fibers business
|
April 09, 2001 | XVIth Congress of the European Association of Urology (EAU): New compound proves to be effective regardless of severity of erectile function difficulties, cause or age
|
April 09, 2001 | Bayer subsidiary Wolff Walsrode to divest Covexx Films business to Wipak of Finland
|
March 15, 2001 | Significant improvement in Health Care earnings
|
March 15, 2001 | Bayer divests its remaining 30% stake in Agfa-Gevaert N.V.
|
March 06, 2001 | Bayer increases dividend to EUR 1.40
|
February 01, 2001 | Bayer acquires a leading maize herbicide in Europe
|
January 16, 2001 | Bayer and CuraGen Enter into two Landmark Agreements
|
January 10, 2001 | Bayer and Millennium announce genome-derived oncology drug candidate selected for first human studies
|
January 10, 2001 | Bayer sells its interest in titanium dioxide joint venture
|
collect